Interleukin-2-Inducible T-cell Kinase (ITK) signaling regulates non-canonical regulatory T cells

被引:0
|
作者
Mammadli, Mahinbanu [1 ]
Harris, Rebecca [1 ]
May, Adriana [1 ]
Gentile, Teresa [1 ]
Karimi, Mobin A. [1 ]
机构
[1] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
来源
JOURNAL OF IMMUNOLOGY | 2021年 / 206卷
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells
    Mammadli, Mahinbanu
    Harris, Rebecca
    Suo, Liye
    May, Adriana
    Gentile, Teresa
    Waickman, Adam T.
    Bah, Alaji
    August, Avery
    Nurmemmedov, Elmar
    Karimi, Mobin
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (12):
  • [2] Interleukin-2-Inducible T-Cell Kinase (ITK) Inhibitors for the Treatment of T-Cell Lymphoproliferative Disorders
    Reneau, John C.
    Hwang, Steven R.
    Murga-Zamalloa, Carlos A.
    Buggy, Joseph J.
    Janc, James W.
    Wilcox, Ryan A.
    BLOOD, 2018, 132
  • [3] Interleukin-2-Inducible T-Cell Kinase (ITK) Deficiency - Clinical and Molecular Aspects
    Sujal Ghosh
    Kirsten Bienemann
    Kaan Boztug
    Arndt Borkhardt
    Journal of Clinical Immunology, 2014, 34 : 892 - 899
  • [4] Interleukin-2-Inducible T-Cell Kinase (ITK) Deficiency - Clinical and Molecular Aspects
    Ghosh, Sujal
    Bienemann, Kirsten
    Boztug, Kaan
    Borkhardt, Arndt
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (08) : 892 - 899
  • [5] Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma
    Sami Mamand
    Rebecca L. Allchin
    Matthew J. Ahearne
    Simon D. Wagner
    Scientific Reports, 8
  • [6] Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma
    Mamand, Sarni
    Allchin, Rebecca L.
    Ahearne, Matthew J.
    Wagner, Simon D.
    SCIENTIFIC REPORTS, 2018, 8
  • [7] Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT
    Mammadli, Mahinbanu
    Huang, Weishan
    Harris, Rebecca
    Sultana, Aisha
    Cheng, Ying
    Tong, Wei
    Pu, Jeffery
    Gentile, Teresa
    Dsouza, Shanti
    Yang, Qi
    Bah, Alaji
    August, Avery
    Karimi, Mobin
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [8] Interleukin-2-inducible T Cell Kinase (Itk) Network Edge Dependence for the Maturation of iNKT Cell
    Qi, Qian
    Xia, Mingcan
    Bai, Yuting
    Yu, Sanhong
    Cantorna, Margherita
    August, Avery
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (01) : 138 - 146
  • [9] A negative role for the interleukin-2-inducible T-cell kinase (ITK) in human Foxp3+ TREG differentiation
    Mamontov, Polina
    Eberwine, Ryan A.
    Perrigoue, Jackie
    Das, Anuk
    Friedman, Joshua R.
    Mora, J. Rodrigo
    PLOS ONE, 2019, 14 (04):
  • [10] Therapeutic Targeting of Interleukin-2-Inducible T-Cell Kinase (ITK) for Cancer and Immunological Disorders: Potential Next-Generation ITK Inhibitors
    Ahmed, Shazia
    Saeed, Mohammad Umar
    Choudhury, Arunabh
    Mohammad, Taj
    Hussain, Afzal
    Alajmi, Mohamed F.
    Yadav, Dharmendra Kumar
    Hassan, Md Imtaiyaz
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2025, 29 (03) : 105 - 115